The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis.
Lars BossenTobias Stemann LauMette Bak NielsenMarlene Christina NielsenAstrid Højmark AndersenPeter OttSabine BeckerHenning GlerupLise SvenningsenMartin EivindsonLinda KornerupNiels Bjørndal KjeldsenAnders NeumannHolger Jon MøllerPeter JepsenHenning GrønbækPublished in: Hepatology communications (2023)
In PBC patients, sCD163 levels correlated with liver disease severity and treatment response to UDCA. Further, after 6 months of UDCA treatment, we observed a decrease in sCD163, which may be related to the treatment.
Keyphrases